Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 by Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder

Get full text

Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome by Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wesley R. Zemrak, David B. Seder

Get full text

Cefepime-induced neurotoxicity: a systematic review by Lauren E. Payne, David J. Gagnon, Richard R. Riker, David B. Seder, Elizabeth K. Glisic, Jane G. Morris, Gilles L. Fraser

Get full text

Community consultation for Exception from Informed consent (EFIC) before and during the COVID-19 pandemic by David J. Gagnon, Richard R. Riker, Frank Chessa, Christine Lord, Ashley Eldridge, Meghan Searight, Sarah Bockian, Barbara McCrum, Teresa L. May, Douglas Sawyer, David B. Seder

Get full text

Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational Study by Chelsea Wampole, PharmD, Ariel McKenna, DO, Richard R. Riker, MD, Teresa L. May, DO, David B. Seder, MD, Dawn Abram, MS, Gilles L. Fraser, PharmD, David J. Gagnon, PharmD

Get full text

Evaluation of Free Valproate Concentration in Critically Ill Patients by Caitlin S. Brown, PharmD, BCCCP, JiTong Liu, PharmD, Richard R. Riker, MD, FCCM, Kristin C. Mara, MS, Alejandro A. Rabinstein, MD, Gilles L. Fraser, PharmD, MCCM, Teresa L. May, DO, David Seder, MD, FCCM, David J. Gagnon, PharmD, BCCCP, FCCM

Get full text

Derivation and Validation of a New Equation for Estimating Free Valproate Concentration in Critically Ill Adult Patients by Ji Tong Liu, PharmD, BCCCP, Caitlin S. Brown, PharmD, BCCCP, FCCM, Kristin C. Mara, MS, Richard R. Riker, MD, FCCM, Alejandro A. Rabinstein, MD, Gilles L. Fraser, PharmD, MCCM, Teresa L. May, DO, Kaitlin J. Armstrong, PharmD, David B. Seder, MD, FCCM, David J. Gagnon, PharmD, BCCCP, FCCM

Get full text